Factor VII deficiency and surgery. Is preoperative replacement therapy necessary?

Area of Science:

• Hematology
• Coagulation Disorders
• Surgical Hemostasis

Background:

• Congenital factor VII deficiency is a rare inherited bleeding disorder.
• Factor VII is a crucial protein in the extrinsic pathway of the coagulation cascade.
• Management guidelines often recommend prophylactic blood-product replacement before invasive procedures.

Observation:

• A patient with 12% factor VII levels underwent gynecologic surgery without prophylactic replacement and experienced minimal blood loss.
• A retrospective review of 12 additional patients with factor VII deficiency undergoing surgery without replacement therapy was conducted.
• Surgical bleeding was infrequent across the reviewed patient cohort.

Findings:

• No correlation was identified between factor VII levels and the occurrence or severity of surgical hemorrhage.
• Patients experiencing bleeding may have concurrent prolonged bleeding times or recent aspirin ingestion.
• Routine preoperative factor replacement therapy appears unnecessary for most factor VII deficient patients.

Implications:

• This study challenges the routine use of prophylactic factor replacement in factor VII deficiency.
• Preoperative assessment should consider bleeding time and medication history alongside factor levels.
• Availability of replacement therapy for intraoperative use is recommended, but routine administration may be avoided.